Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Non-Current Deferred Tax Liability came in at $410.0 million in Q2 2026, down 17.34% year-over-year from $496.0 million in Q2 2025, and up 12.02% quarter-over-quarter from $366.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Non-Current Deferred Tax Liability across 10 years of filings, most recently posting $410.0 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 17.34% year-over-year to $410.0 million; the TTM figure through Jun 2026 stood at $410.0 million (down 17.34% YoY), while the FY2025 annual figure was $382.0 million, down 53.01% from the prior year.
- Non-Current Deferred Tax Liability came in at $410.0 million for Q2 2026 at Elanco Animal Health, up from $366.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2022 to a low of $366.0 million in Q1 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $611.4 million, with a median of $578.5 million recorded in 2022.
- Year-over-year, Non-Current Deferred Tax Liability grew 6.13% in 2023 and slumped 53.01% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $1.1 billion in 2022, then fell by 9.89% to $966.0 million in 2023, then retreated by 15.84% to $813.0 million in 2024, then sank by 53.01% to $382.0 million in 2025, then climbed by 7.33% to $410.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $410.0 million in Q2 2026, $366.0 million in Q1 2026, and $382.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.53 Bn | 40.34 Bn | 779.09 Mn |
| 2 | Zoetis | 30.65 Bn | 28.97 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.81 Bn | 11.28 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 410.00 Mn |
| Mar 31, 2026 | 366.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 478.00 Mn |
| Jun 30, 2025 | 496.00 Mn |
| Mar 31, 2025 | 481.00 Mn |
| Dec 31, 2024 | 813.00 Mn |
| Sep 30, 2024 | 539.00 Mn |
| Jun 30, 2024 | 524.00 Mn |
| Mar 31, 2024 | 530.00 Mn |
| Dec 31, 2023 | 966.00 Mn |
| Sep 30, 2023 | 643.00 Mn |
| Jun 30, 2023 | 658.00 Mn |
| Mar 31, 2023 | 663.00 Mn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 618.00 Mn |
| Jun 30, 2022 | 620.00 Mn |
| Mar 31, 2022 | 747.00 Mn |
| Dec 31, 2021 | 1.12 Bn |
| Sep 30, 2021 | 726.00 Mn |